New Key Statistics Module, Z-Score and F-Score
SZSE:300558 Key Ratios
Market Cap ¥ M | 15,559.31 |
Enterprise Value ¥ M | 17,868.38 |
P/E(ttm) | 39.98 |
PE Ratio without NRI | 39.89 |
Forward PE Ratio | -- |
Price/Book | 2.82 |
Price/Sales | 5.90 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.08 |
Revenue (TTM) ¥ M | 2,660.00 |
EPS (TTM) ¥ | 0.93 |
Beneish M-Score | -3.11 |
10-y EBITDA Growth Rate % | 7.60 |
5-y EBITDA Growth Rate % | 11.20 |
y-y EBITDA Growth Rate % | 86.00 |
EV-to-EBIT | 40.59 |
EV-to-EBITDA | 40.59 |
PEG | 3.56 |
Shares Outstanding M | 418.49 |
Net Margin (%) | 14.84 |
Operating Margin % | 15.85 |
Pre-tax Margin (%) | 14.80 |
Quick Ratio | 0.67 |
Current Ratio | 0.91 |
ROA % (ttm) | 4.50 |
ROE % (ttm) | 7.60 |
ROIC % (ttm) | 5.27 |
Dividend Yield % | 0.18 |
Altman Z-Score | 3.34 |
SZSE:300558 Number of Guru Trades
SZSE:300558 Volume of Guru Trades
Gurus Latest Trades with SZSE:300558
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300558 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Betta Pharmaceuticals Co Ltd Insider Transactions
No Available Data